Waters Corporation
NYSE:WATMedical - Diagnostics & Research
-$0.57 today
- Market cap
- $45.81B
- Beta
- 1.20
- P/E (TTM)
- 65.2
- EPS (TTM)
- $5.47
Volume 0.73M
Average 1.03M
WAT Total Current Assets
All assets expected to be converted to cash or used up within one year.
Waters CorporationNYSE: WAT
Total Current Assets · Q2 FY2026 · quarter ended Jul 2026
Total current assets rises 150.5% from a year ago
Total current assets stood at $4.47B at the end of Q2 FY2026, up 150.5% from a year earlier and up 9.9% from the prior quarter. Over 3 fiscal years it compounded at +6.8% a year.
Context
- Total current assets amounted to 18.0% of total assets at the end of Q2 FY2026, down 19.7 pp from a year earlier.
- Total current assets increased in 1 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether total current assets keeps rising in the next quarterly balance sheet after a +150.5% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Current Assets history
USD · from the balance sheet
- Latest · FY2025
- 2.15B USD
- Year-over-year change
- +28.7%
- 4-year CAGR
- +7.2%
| Period | Period end | Total Current Assets | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 2.15B | +28.7% |
| FY2024 | 2024-12-31 | 1.67B | -4.8% |
| FY2023 | 2023-12-31 | 1.75B | -0.6% |
| FY2022 | 2022-12-31 | 1.76B | +8.3% |
| FY2021 | 2021-12-31 | 1.63B | — |
Total Current Assets vs competitors
How WAT compares with its peers on the latest reported figures
- WAT's Jul 2026 total current assets of $4.47B is the 4th highest of the 7 companies compared; the peer median is $3.5B.
- Its year-over-year change of +150.5% is the highest of 7, against a peer median of +9.3%.
- Total current assets amounts to 18.0% of total assets for WAT, versus a peer median of 28.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Sep 2026 | $25.62B | +14.9% | +4.4% | 22.4% | |
| Sep 2026 | $14.79B | +53.9% | -7.0% | 15.9% | |
| Jul 2026 | $4.69B | +10.3% | +6.7% | 33.6% | |
| Jul 2026 | $4.47B | +150.5% | +6.8% | 18.0% | |
| Jul 2026 | $2.3B | +2.8% | -12.0% | 19.1% | |
| Jun 2026 | $2.23B | +2.9% | +1.5% | 36.8% | |
| Jun 2026 | $1.35B | +8.3% | -0.3% | 36.7% | |
| Peer median (excluding WAT) | $3.5B | +9.3% | +0.6% | 28.0% | |
Competitors are the stored peer set for WAT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 501.23M | 480.53M | 395.08M | 324.42M | 587.83M |
| Short-term Investments | 68.05M | 862K | 898K | 934K | 0 |
| Net Receivables | 612.65M | 722.89M | 702.17M | 733.37M | 828.84M |
| Inventory | 356.1M | 455.71M | 516.24M | 477.26M | 572.37M |
| Other Current Assets | 90.91M | 103.91M | 138.49M | 133.13M | 158.6M |
| Total Current Assets | 1.63B | 1.76B | 1.75B | 1.67B | 2.15B |
| Property, Plant & Equipment (Net) | 632.65M | 668.72M | 723.66M | 725.39M | 722.81M |
| Goodwill | 437.87M | 430.33M | 1.31B | 1.3B | 1.34B |
| Intangible Assets | 242.4M | 227.4M | 629.19M | 567.91M | 558.18M |
| Long-term Investments | 0 | 0 | 0 | 0 | 346K |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 153.08M | 191.1M | 215.69M | 295.67M | 307.49M |
| Total Non-current Assets | 1.47B | 1.52B | 2.87B | 2.88B | 2.93B |
| Total Assets | 3.09B | 3.28B | 4.63B | 4.55B | 5.08B |
| Account Payables | 96.8M | 93.3M | 84.71M | 99.93M | 103.78M |
| Short-term Debt | 0 | 50M | 50M | 0 | 460M |
| Tax Payables | 61.28M | 132.55M | 120.26M | 158.66M | 0 |
| Deferred Revenue | 227.56M | 227.91M | 256.68M | 250.81M | 266.54M |
| Other Current Liabilities | 256.25M | 243.6M | 238.07M | 243.22M | 330.3M |
| Total Current Liabilities | 680.51M | 785.74M | 789.58M | 789.76M | 1.24B |
| Long-term Debt | 1.51B | 1.52B | 2.31B | 1.63B | 947.45M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 473.38M | 404.24M | 322.49M | 258.73M | 275.82M |
| Total Non-current Liabilities | 2.05B | 1.99B | 2.69B | 1.94B | 1.28B |
| Total Liabilities | 2.73B | 2.78B | 3.48B | 2.73B | 2.52B |
| Common Stock | 1.62M | 1.62M | 1.63M | 1.63M | 1.63M |
| Retained Earnings | 7.8B | 8.51B | 9.15B | 9.79B | 10.43B |
| Accumulated OCI | (111.87M) | (141.57M) | (134.12M) | (155.28M) | (125.45M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 367.55M | 504.49M | 1.15B | 1.83B | 2.56B |
| Total Debt | 1.6B | 1.66B | 2.44B | 1.7B | 1.49B |
| Net Debt | 1.1B | 1.18B | 2.05B | 1.38B | 903.25M |
Waters Corporation
NYSE:WAT
Intrinsic Alpha fair value
Locked
Current Price
$466.10
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.